April 2, 2017| Israeli biomed company CollPlant, a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant human, “rhCollagen”), has just provided a commercial and operational update in its annual reports. The company has progressed to the commercial stage with the signing of Vergenix™FG and Vergenix™STR distribution and sales agreements in Europe. […]